This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
U.S. stock prospects | Wall Street sings praises! Tesla soared nearly 5%, reaching a two-month high; Chinese concept stocks stepping on the gas? Alibaba's stock price hits a one-year high, ke holdings skyrocketed by over 7% overnight.
Up more than 120% year-to-date! Sea rose more than 10% on the 3rd day, with many major banks setting a high target price of $96; the two-year cumulative increase is as high as 490%! Palantir's overnight stock price hit another record high, rising more than 25% since its inclusion in the s&p 500 index announcement.
Express News | Regeneron Pharmaceuticals Inc : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $1077 From $1175
Truist Financial Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Announces Target Price $1,200
Truist Financial analyst Robyn Karnauskas maintains $Regeneron Pharmaceuticals(REGN.US)$ with a buy rating, and sets the target price at $1,200.According to TipRanks data, the analyst has a success
Regeneron Stock Slides After Court Rejects Injunction Against Eye Drug Biosimilar, Truist Says
Overweight Quality Stocks With Positive EPS Revision - MS
Express News | Wells Fargo & Co maintains the target price of Regeneron Pharmaceuticals at $1200.00.
4D Molecular Therapeutics Downgraded at Cantor Following Wet AMD Asset Data
Wells Fargo Reiterates Overweight on Regeneron Pharmaceuticals, Maintains $1200 Price Target
Smart Money Is Betting Big In REGN Options
Regeneron Falls After Judge Denies Motion for Injunction in a Patent Case With Amgen
Regeneron Pharmaceuticals on Track for Largest Percent Decrease Since June 2023 -- Data Talk
Regeneron, Sanofi Say Eosinophilic Esophagitis Drug Recommended for Children in EU
Express News | Dupixent® (Dupilumab) Recommended for EU Approval by the Chmp to Treat Eosinophilic Esophagitis (Eoe) in Children as Young as 1 Year Old
The Best Biotech Plays Outside the GLP-1 Weight-loss Market
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
Regeneron Pharma Price Target Maintained With a $1282.00/Share by RBC Capital
RBC Capital Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,282
RBC Capital analyst Brian Abrahams maintains $Regeneron Pharmaceuticals(REGN.US)$ with a buy rating, and maintains the target price at $1,282.According to TipRanks data, the analyst has a success
BMO Capital Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,300
BMO Capital analyst Evan Seigerman maintains $Regeneron Pharmaceuticals(REGN.US)$ with a buy rating, and maintains the target price at $1,300.According to TipRanks data, the analyst has a success
BofA Securities Initiates Regeneron Pharmaceuticals(REGN.US) With Sell Rating, Announces Target Price $805
BofA Securities analyst Alec Stranahan initiates coverage on $Regeneron Pharmaceuticals(REGN.US)$ with a sell rating, and sets the target price at $805.According to TipRanks data, the analyst has a